Evidence map›Paper›PMID 23938298›Full record

ArticleMolecular and cellular biology2013

Activation of a novel ubiquitin-independent proteasome pathway when RNA polymerase II encounters a protein roadblock.

Yi Ban, Chia-Wen Ho, Ren-Kuo Lin, Yi Lisa Lyu, Leroy F Liu

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Yi BanDepartment of Pharmacology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, New Jersey, USA.
Chia-Wen Ho
Ren-Kuo Lin
Yi Lisa Lyu
Leroy F Liu
Johnson University · USRutgers, The State University of New Jersey · US

Funding

MECHANISMS OF ACTION IN ANTITUMOR DRUGSR01CA039662 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI LIU, LEROY F · 1985 to 2013
$3.8M
Mechanism of Action of TOP2-Directed Anticancer DrugsR01CA102463 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI LIU, LEROY F · 2004 to 2012
$2.6M
NCI NIH HHS R01 CA039662NCI NIH HHS R01 CA102463
6 · The paper itself

Abstract

Topoisomerase IIβ (Top2β)-DNA cleavage complexes are known to arrest elongating RNA polymerase II (RNAPII), triggering a proteasomal degradation of the RNAPII large subunit (RNAPII LS) and Top2β itself as a prelude to DNA repair. Here, we demonstrate that the degradation of Top2β occurs through a novel ubiquitin-independent mechanism that requires only 19S AAA ATPases and 20S proteasome. Our results suggest that 19S AAA ATPases play a dual role in sensing the Top2β cleavage complex and coordinating its degradation by 20S proteasome when RNAPII is persistently stalled by the Top2β protein roadblock. Clarification of this transcription-associated proteasome pathway could shed light on a general role of 19S AAA ATPases in processing tight protein-DNA complexes during transcription elongation.

Indexed as

DNA RepairTranscription Elongation, GeneticAdenosine TriphosphatasesAnimalsDNADNA-Binding ProteinsDNA Topoisomerases, Type IIEmbryo, MammalianFibroblastsHeLa CellsHumansMiceProteasome Endopeptidase ComplexProtein BindingRNA Polymerase IIUbiquitinAdenosine TriphosphatasesDNADNA-Binding ProteinsDNA Topoisomerases, Type IIProteasome Endopeptidase ComplexRNA Polymerase IIRNA polymerase II largest subunitUbiquitin

Identifiers

PMID23938298
PMCPMC3811683
OpenAlexW2112244212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.